Premium
Attention‐Deficit Hyperactivity Disorder and Long‐QT Syndrome: Risky Business
Author(s) -
KALTMAN JONATHAN R.,
BERUL CHARLES I.
Publication year - 2015
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/jce.12744
Subject(s) - medicine , family medicine , columbia university , library science , gerontology , sociology , media studies , computer science
During the past decade, the concern about cardiovascular risks of stimulant medications for the treatment of attentiondeficit hyperactivity disorder (ADHD) has swung from panicked worry to more reasoned reflection. Recent large epidemiological studies have reassured the scientific, medical, and patient communities that a safety signal does not exist for the occurrence of cardiac events in patients receiving stimulant therapy. In this issue of the Journal, Zhang et al. provide new data on a previously understudied population in this arena, patients with the long-QT syndrome (LQTS).1 Will the pendulum swing again?